Xilio Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2020 | — | — | $-8.1M |
| Jun 2020 | — | — | $-11.5M |
| Sep 2020 | — | $-14.6M | $-14.8M |
| Dec 2020 | — | — | $-20.8M |
| Mar 2021 | — | $-16.5M | $-16.7M |
| Jun 2021 | — | $-23.0M | $-23.2M |
| Sep 2021 | — | $-16.0M | $-16.3M |
| Dec 2021 | — | $-19.6M | $-19.7M |
| Mar 2022 | — | $-21.2M | $-21.4M |
| Jun 2022 | — | $-24.6M | $-24.6M |
| Sep 2022 | — | $-20.2M | $-19.8M |
| Dec 2022 | — | $-23.2M | $-22.5M |
| Mar 2023 | — | $-23.5M | $-22.6M |
| Jun 2023 | — | $-20.1M | $-19.4M |
| Sep 2023 | — | $-17.4M | $-16.7M |
| Dec 2023 | — | $-18.1M | $-17.7M |
| Mar 2024 | — | $-17.5M | $-17.2M |
| Jun 2024 | $2.4M | $-14.7M | $-13.9M |
| Sep 2024 | $2.3M | $-14.8M | $-14.0M |
| Dec 2024 | — | $-13.6M | $-13.1M |
| Mar 2025 | $2.9M | $-13.9M | $-13.3M |
| Jun 2025 | $8.1M | $-14.4M | $-15.8M |
| Sep 2025 | $19.1M | $-1.9M | $-16.3M |
| Dec 2025 | $13.7M | $-11.8M | $10.4M |
| Mar 2026 | $12.6M | $-14.1M | $-9.5M |
| Jun 2026 | $18.7M | $-3.5M | $-6.4M |